Notice to early expire RFA-FD-19-020 "Novel Approaches to Translational Evidence Generation to Advance Coordinated Registry Networks (CRNs) via Big Data Analytics Using Disparate Data Sources (U01 Clinical Trial Optional)"

Notice Number: NOT-FD-19-009

Key Dates
Release Date: March 22, 2019

Related Announcements
RFA-FD-19-020

Issued by
U.S. Food and Drug Administration (FDA)
Center for Devices and Radiological Health (CDRH)

Purpose

This notice is to early expire RFA-FD-19-020 "Novel Approaches to Translational Evidence Generation to Advance Coordinated Registry Networks (CRNs) via Big Data Analytics Using Disparate Data Sources (U01 Clinical Trial Optional)".  A replacement FOA will be published.

Inquiries

Please direct all inquiries to:

Kiara Fowler
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Telephone: 240-402-3099
Email: Kiara.Fowler@fda.hhs.gov